2020 American Transplant Congress
Incidence of Cytomegalovirus and Role of Reduced Dose Valganciclovir in Kidney Transplant Recipients
*Purpose: Valganciclovir (VGC) is the optimal agent for preventing cytomegalovirus (CMV) but its use is limited by cost and leukopenia. Reduced dose VGC (rVGC) has…2020 American Transplant Congress
Bacterial Infection in Compensated Cirrhosis Predicts Inpatient Mortality and Readmission with Decompensation
1Weill Cornell Medicine, New York, NY, 2Cedars Sinai, Los Angeles, CA
*Purpose: Identify the impact of bacterial infection on inpatient mortality and new decompensation in hospitalized patients with compensated cirrhosis from a nationally representative database.*Methods: This…2020 American Transplant Congress
ATHENA – Patient and Allograft Outcome Differences after Kidney Transplantation – Germany vs. France
*Purpose: In the ATHENA trial [NCT01843348], efficacy and safety of everolimus in combination with tacrolimus [EVR+TAC] or cyclosporine A [EVR+CyA] vs. TAC and mycophenolic acid…2020 American Transplant Congress
Analyzing the Effect of a Closed Incision Negative Pressure Wound Therapy System on Wound Complications and Surgical Site Infections in Kidney Transplant Recipients: A Propensity Score Matched Analysis
Transplantation Services, Royal Prince Alfred Hospital, Sydney, Australia
*Purpose: The purpose of this study is to determine if a closed incision negative pressure wound therapy (ciNPWT) system prevents wound complications and surgical site…2020 American Transplant Congress
Efficacy and Safety According to Dose of Valganciclovir for Cytomegalovirus Prophylaxis in Transplantation Network Meta Analysis
Inha University, Incheon, Korea, Republic of
*Purpose: Valgancivlovir is importantly used to prevent post-transplant CMV infection among kidney transplantation patients. However, the dose of such drug being used still remains controversial…2020 American Transplant Congress
Factors Associated with High Mortality in Acute on Chronic Liver Failure Patients Admitted to the Intensive Care Unit, Single Center Experience
*Purpose: ACLF is a newly defined syndrome in the background of a chronic liver disease characterized by acute decompensation, organ failure and high mortality at…2020 American Transplant Congress
Outcome after Kidney Transplantation in Hepatitis Surface Antigen-Positive Patients
Department of Surgery, Seoul National University Hospital, Seoul, Korea, Republic of
*Purpose: Because of the low prevalence of Hepatitis Surface Antigen (HBsAg)-positive patients, only a few reports have evaluated the actual outcome of these patients after…2020 American Transplant Congress
Evaluation of Oral Candidiasis Incidence at Large Academic Medical Center in Absence of Pharmacologic Prophylaxis at Discharge
*Purpose: Oral candidiasis (OC) is a common complication in solid organ transplant recipients. Despite AST guidelines recommending against universal prophylaxis, it has become common practice…2020 American Transplant Congress
Effect of Rituximab Dose as Induction Therapy in ABO Incompatible Living Kidney Transplantation A Systemic Review and Network Meta Analysis
1Inha University, Incheon, Korea, Republic of, 2Keimyung University, Daegu, Korea, Republic of
*Purpose: ABO-incompatible living kidney transplantation (ABOILKT) has steadily become more widespread. However, the optimal immunosuppressive regimen for ABOILKT remains uncertain. We aimed to determine the…2020 American Transplant Congress
Characteristics of Kidney Transplant Patients Diagnosed with Histoplasmosis
University of Nebraska Medical Center, Omaha, NE
*Purpose: Histoplasmosis is responsible for the greatest number of hospitalizations and deaths due to endemic mycoses in the United States. Although lying near the western…
- « Previous Page
- 1
- …
- 31
- 32
- 33
- 34
- 35
- …
- 84
- Next Page »